{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:07Z","timestamp":1792737667248,"version":"4.5.0"},"reference-count":26,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/fixa7908","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:09:25Z","timestamp":1769483365000},"page":"199-207","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effect evaluation of interventional embolization combined with pingyangmycin injection in the treatment of trunk and limbs Kaposi type hemangioendothelioma"],"prefix":"10.62347","volume":"16","author":[{"given":"Shiwei","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.soc.2022.03.014","article-title":"Management of vascular sarcoma","volume":"31","author":"Subramaniam","year":"2022","unstructured":"Subramaniam A, Giani C, Napolitano A, Ravi V, Frezza AM and Jones RL. Management of vascular sarcoma. Surg Oncol Clin N Am 2022; 31: 485-510.","journal-title":"Surg Oncol Clin N Am"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Papke DJ Jr and Hornick JL. What is new in endothelial neoplasia? Virchows Arch 2020; 476: 17-28.","DOI":"10.1007\/s00428-019-02651-4"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/ijc.30216","article-title":"Treatment of kaposiform hemangioendothelioma and tufted angioma","volume":"139","author":"Liu","year":"2016","unstructured":"Liu XH, Li JY, Qu XH, Yan WL, Zhang L, Yang C and Zheng JW. Treatment of kaposiform hemangioendothelioma and tufted angioma. Int J Cancer 2016; 139: 1658-66.","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12887-023-04407-1","article-title":"Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report","volume":"23","author":"Liu","year":"2023","unstructured":"Liu L, Gu W, Teng L, Xu Y, Zheng F, Hu M, Lu M and Xu X. Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report. BMC Pediatr 2023; 23: 574.","journal-title":"BMC Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaad.2025.03.023","article-title":"Efficacy and safety of high-vs low-dose sirolimus in patients with kaposiform hemangioendothelioma: a randomized clinical trial","volume":"93","author":"Zhou","year":"2025","unstructured":"Zhou J, Lan Y, Qiu T, Zhang Z, Gong X, Zhang X, Yang C, Zhou Z, Zhang Y, Yang M, Fu J, He C, Peng Q, Hu F, Xia C, Kong F, Chen S and Ji Y. Efficacy and safety of high-vs low-dose sirolimus in patients with kaposiform hemangioendothelioma: a randomized clinical trial. J Am Acad Dermatol 2025; 93: 124-131.","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s12105-021-01316-6","article-title":"Kaposiform hemangioendothelioma of the oral cavity: a rare tumor with an unusual location","volume":"15","author":"TML","year":"2021","unstructured":"Morais TML, Sánchez-Romero C, Ribeiro L, Faé DS, Verner FS, de Almeida OP and de Aquino SN. Kaposiform hemangioendothelioma of the oral cavity: a rare tumor with an unusual location. Head Neck Pathol 2021; 15: 1421-1425.","journal-title":"Head Neck Pathol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ijc.35207","article-title":"Sirolimus for kaposiform hemangioendothelioma: potential mechanisms of action and resistance","volume":"156","author":"Qiu","year":"2025","unstructured":"Qiu T, Xiang S, Zhou J, Yang M, Lan Y, Zhang X, Gong X, Zhang Z and Ji Y. Sirolimus for kaposiform hemangioendothelioma: potential mechanisms of action and resistance. Int J Cancer 2025; 156: 689-699.","journal-title":"Int J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rikhotso RE and Alharbi AA. Management of refractory mandibular kaposiform hemangioendothelioma with Sirolimus: a case report and review of the literature. J Oral Maxillofac Surg 2021; 79: 2086.e1-2086.e8.","DOI":"10.1016\/j.joms.2021.05.017"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1111\/bcp.15202","article-title":"Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants","volume":"88","author":"Harbers","year":"2022","unstructured":"Harbers VEM, van der Salm N, Pegge SAH, van der Vleuten CJM, Verhoeven BH, Vrancken SLAG, Schultze Kool LJ, Fuijkschot J and Te Loo DMMWM. Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants. Br J Clin Pharmacol 2022; 88: 2769-2781.","journal-title":"Br J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/ijc.35344","article-title":"Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma","volume":"156","author":"Zhou","year":"2025","unstructured":"Zhou J, Qiu T, Zhang Z, Lan Y, Huo R, Xiang B, Chen S, Qiu L, Xia C, Xu X, Li J, Ma Y, Yao W, Wang Z, Dong C, Qin Z, Tai M, Guo L, He X, Gu S, Li L, Hou F, Cai Y, Wang H, Wang J, Jiang X, Zheng J, Li K and Ji Y. Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma. Int J Cancer 2025; 156: 1986-1994.","journal-title":"Int J Cancer"},{"key":"ref10","unstructured":"Zhang GL, Gao Y, Liu Y, Gu F, Su W, Qin Q, Chen JY, Zhang HH, Yang J, Liu XY. Refractory kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: clinical analysis of 10 cases. Zhonghua Er Ke Za Zhi 2017; 55: 700-704."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.25259\/IJDVL_799_19","article-title":"Progressive kaposiform hemangioendothelioma and sirolimus-related severe thrombocytopenia","volume":"89","author":"Ying","year":"2023","unstructured":"Ying H, Qiao C, Wang L and Lin X. Progressive kaposiform hemangioendothelioma and sirolimus-related severe thrombocytopenia. Indian J Dermatol Venereol Leprol 2023; 89: 54-59.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.abd.2021.07.010","article-title":"Kaposiform hemangioendothelioma and tufted angioma: two entities of the same clinicopathological spectrum","volume":"98","author":"Nieto-Benito LM","year":"2023","unstructured":"Nieto-Benito LM, Huerta-Aragonés J, Parra-Blanco V and Campos-Domínguez M. Kaposiform hemangioendothelioma and tufted angioma: two entities of the same clinicopathological spectrum. An Bras Dermatol 2023; 98: 391-394.","journal-title":"An Bras Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/cup.14066","article-title":"Aberrant cytoplasmic connexin43 expression as a helpful marker in vascular neoplasms","volume":"48","author":"Frings","year":"2021","unstructured":"Frings VG, Goebeler M, Schilling B and Kneitz H. Aberrant cytoplasmic connexin43 expression as a helpful marker in vascular neoplasms. J Cutan Pathol 2021; 48: 1335-1341.","journal-title":"J Cutan Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s12098-021-03817-2","article-title":"Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon","volume":"88","author":"Pati","year":"2021","unstructured":"Pati S, Das MK, Rana A, Das E, Sarkar S, Sherpa N and Datta S. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon. Indian J Pediatr 2021; 88: 1142-1144.","journal-title":"Indian J Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Lin N and Zhao X. Unique Cobb syndrome with Kaposi hemangioendothelioma\/tufted angioma as dominant phenotype: a case report. World J Pediatr Surg 2023; 6: e000695.","DOI":"10.1136\/wjps-2023-000695"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1111\/jocd.14500","article-title":"Animal experimental research of intralesional pingyangmycin and pingyangmycin in the treatment of xanthoma","volume":"21","author":"Lin","year":"2022","unstructured":"Lin XZ, Hu H, Zhao X, Qian YX, Wang H, Jiang H and Zhu L. Animal experimental research of intralesional pingyangmycin and pingyangmycin in the treatment of xanthoma. J Cosmet Dermatol 2022; 21: 2977-2983.","journal-title":"J Cosmet Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12886-025-04154-0","article-title":"Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations","volume":"25","author":"Li","year":"2025","unstructured":"Li Y, Wang L, Song D, Jiao B, Li J, Zhou J and Guo L. Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations. BMC Ophthalmol 2025; 25: 319.","journal-title":"BMC Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.21037\/atm-21-2018","article-title":"Clinical evaluation and animal experimental study of different mass concentrations of pingyangmycin in the local injection treatment of lip venous malformation","volume":"9","author":"Yuan","year":"2021","unstructured":"Yuan W, Wang X, Xue L and Zhang F. Clinical evaluation and animal experimental study of different mass concentrations of pingyangmycin in the local injection treatment of lip venous malformation. Ann Transl Med 2021; 9: 929.","journal-title":"Ann Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/lrb.2021.0053","article-title":"Successful sclerotherapy for cervicofacial macrocystic lymphatic malformations using polidocanol and pingyangmycin combined foam sclerosants","volume":"20","author":"Wang","year":"2022","unstructured":"Wang Q, Zhou Q, Zhao Z, Liu C and Zheng J. Successful sclerotherapy for cervicofacial macrocystic lymphatic malformations using polidocanol and pingyangmycin combined foam sclerosants. Lymphat Res Biol 2022; 20: 507-513.","journal-title":"Lymphat Res Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jpedsurg.2023.12.003","article-title":"Kaposiform hemangioendothelioma with bone destruction: a 16-year follow-up cohort study of the clinical characteristics and prognosis","volume":"59","author":"Qiu","year":"2024","unstructured":"Qiu T, Zhang Z, Liu J, Zhou J, Gong X, Lan Y, Zhang X, Chen S and Ji Y. Kaposiform hemangioendothelioma with bone destruction: a 16-year follow-up cohort study of the clinical characteristics and prognosis. J Pediatr Surg 2024; 59: 599-604.","journal-title":"J Pediatr Surg"},{"key":"ref21","unstructured":"Xing J, Zhang N, Chen B, Tong ZC, Liu HM and Zhou HZ. Rare adult kaposiform hemangioendothelioma with multiple-bone invasion - clinical experience and literature review. Eur Rev Med Pharmacol Sci 2023; 27: 6653-6661."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1182\/bloodadvances.2022009590","article-title":"Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma\/Kasabach-Merritt phenomenon","volume":"7","author":"Martyanov","year":"2023","unstructured":"Martyanov AA, Tesakov IP, Khachatryan LA, An OI, Boldova AE, Ignatova AA, Koltsova EM, Korobkin JD, Podoplelova NA, Svidelskaya GS, Yushkova E, Novichkova GA, Eble JA, Panteleev MA, Kalinin DV and Sveshnikova AN. Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma\/Kasabach-Merritt phenomenon. Blood Adv 2023; 7: 4936-4949.","journal-title":"Blood Adv"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/ajh.26370","article-title":"Splenic kaposiform hemangioendothelioma presenting as insidious consumptive coagulopathy","volume":"96","author":"Goldenberg","year":"2021","unstructured":"Goldenberg M, Shiel M, Subramanian S, Kalpatthi R, Reyes-Múgica M and Nolfi-Donegan D. Splenic kaposiform hemangioendothelioma presenting as insidious consumptive coagulopathy. Am J Hematol 2021; 96: 1708-1714.","journal-title":"Am J Hematol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"995399","DOI":"10.3389\/fped.2022.995399","article-title":"Case report: kaposi hemangioendothelioma of the right upper limb with the Kasabach-Merritt phenomenon: a potentially lethal diagnostic challenge","volume":"10","author":"Belani","year":"2022","unstructured":"Belani L, Sapuan J, Abdullah S, Hing EY, Loh CK and Alias H. Case report: kaposi hemangioendothelioma of the right upper limb with the Kasabach-Merritt phenomenon: a potentially lethal diagnostic challenge. Front Pediatr 2022; 10: 995399.","journal-title":"Front Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00381-020-04905-y","article-title":"Intracranial kaposiform hemangioendothelioma presenting as epistaxis: a rare case report with review of literature","volume":"37","author":"Das","year":"2021","unstructured":"Das S, Deora H, Rao S, Kandregula S and Narayana SM. Intracranial kaposiform hemangioendothelioma presenting as epistaxis: a rare case report with review of literature. Childs Nerv Syst 2021; 37: 2057-2062.","journal-title":"Childs Nerv Syst"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:30:38Z","timestamp":1792737038000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/16\/1\/ajcr0168527.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/fixa7908","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}